Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cesca Appoints CFO

This article was originally published in Scrip

Executive Summary

Cesca Therapeutics Inc., an autologous cell-based regenerative medicine company, has appointed Michael Bruch chief financial officer (CFO). Bruch joined the company as controller in 2003 and he was appointed interim CFO in May 2015. He has over 25 years of experience in various financial and managerial roles at companies including General Electric and Dada Micro Scan (now Siemens Healthcare).






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts